What is Finasteride Market Size?
Global finasteride market size was valued at USD 106.06 million in 2025 and is anticipated to exhibit a CAGR of 2.8% during the forecast period.
Market Statistics
- 2025 Market Size: USD 106.06 Million
- 2034 Projected Market Size: USD 135.98 Million
- CAGR (2026-2034): 2.8%
- Largest Market: North America
Market Overview
The rising demand for finasteride medication in the marketplace is highly influenced by the presence of a larger number of people suffering from hair loss. In the world, hair loss is becoming a significant factor causing psychological distress among males and females. Approximately two-thirds of men are expected to witness hair loss symptoms by the age of 35. The growing number of companies developing superior hair loss treatment medications, specifically for men, is anticipated to fuel significant demand potential for finasteride.
- For instance, in July 2023, Happy Head, a telemedicine provider, introduced a new hair loss medication formula using latanoprost, minoxidil, and finasteride, constituting 0.005%, 8.0%, and 0.3%, respectively.
Moreover, the uptick in the consumption of finasteride medication in the global space is showcasing a positive outlook. For instance, in November 2023, HanAll Biopharma announced that its monthly sales of 1 mg-based hair loss pills, finasteride, witnessed more than one million sales.
To Understand More About this Research: Request a Free Sample Report
However, the existence of prominent substitutes and alternatives to finasteride in terms of hair loss and benign prostatic hyperplasia applications is expected to restrain market growth in the coming years.
The research report offers a quantitative and qualitative analysis of the finasteride market to enable effective decision-making. It covers the key trends and growth opportunities anticipated to have a favorable impact on the market. Besides, the study covers segment and regional revenue forecasts for market assessment.
Growth Drivers
Rising clinical trials are unraveling the true potential of finasteride, driving the market growth
The presence of several clinical trials demonstrating the effectiveness of finasteride medication in dealing with hair loss and benign prostatic hyperplasia is gaining adoption by healthcare providers. According to a clinical study, the patients in the finasteride group registered a 25% relative decrease in the overall risk of prostate cancer from 24–18%. These types of studies are expected to promote the adoption of finasteride medication in the marketplace.
The growing development of compound hair care medicine is boosting the market growth
Pharmaceutical companies are showing enormous interest in developing advanced therapies, and rising innovations with combination therapies are expected to foster the demand for finasteride in the marketplace. For instance, in November 2023, Mangoceuticals widened its male health product portfolio with the incorporation of a combined hair growth treatment, Grow by MangoRx. It is a combination of biotin, vitamin D3, fenasteride, and minoxidil.
Restraining Factors
The adverse effects of finasteride medication restrain the market growth
The ongoing studies exploring side-effects associated with the oral intake of finasteride pills and enhanced awareness about the numerous medicinal ingredients with the improved availability of the internet are anticipated to lower the demand for finasteride. Based on the existing clinical trials, adverse effects of finasteride include decreased libido, rash, ejaculation issues, erectile dysfunction, and rash.
Key Trends in Finasteride
|
Trend |
Description |
Examples/Drivers |
|
Generic Dominance |
Low-cost versions post-patent expiry expand access. |
Price competition, 60%+ market share in NA/EU |
|
Topical Formulations |
Minoxidil combinations reduce systemic side effects. |
Hair loss focus, improved adherence |
|
Telemedicine Growth |
Online prescriptions via digital dermatology platforms. |
Convenience, APAC expansion |
|
Combination Therapies |
Dutasteride/minoxidil pairings for enhanced efficacy. |
BPH/hair loss dual treatment |
|
Emerging Markets |
India/China demand from hyperlipidemia awareness. |
Healthcare access, projected USD 4.6B by 2035 |
Report Segmentation
The market is primarily segmented based on product, application, distribution channel and region.
|
By Product |
By Application |
By Distribution Channel |
By Region |
|
|
|
|
To Understand the Scope of this Report: Speak to Analyst
By Product Analysis
1mg segment is expected to witness the highest growth during the forecast period
The 1mg segment is expected to witness the highest CAGR during the projected period, primarily driven by the rising number of people suffering from hair loss. The 1 mg dose of finasteride medication is mostly used for the treatment of hair loss among men. As more people show interest in opting for hair care treatments driven by societal perception, professional image, and more, there will be significant demand for finasteride medication in the coming years.
The 5 mg segment led the market with a substantial market size in 2023, largely attributable to its ability to offer effective treatment for prostatic hyperplasia. The growing prevalence of this disease among the larger population is likely to boost the demand for 5-mg-based finasteride in the foreseeable future, as it is approved for benign prostatic hyperplasia by the US Food and Drug Administration.
By Application Analysis
Prostate treatment segment garnered the largest market share in 2025
The prostate treatment garnered the largest market share in 2025 and is likely to retain its market position throughout the forecast period. This can be influenced by the rising utility of finasteride in prostate treatment over hair loss. In this, the prostate enlargement sub-segment received the highest growth due to the superior performance of finasteride in treating prostate enlargement health issues, which is the cause of difficulty in urination among males.
Prostate cancer segment is projected to grow at healthy rate, driven by the increased risk of developing prostate cancer among patients with benign prostatic enlargement. This is driving the demand for the finasteride treatment for benign prostatic enlargement, with the objective of lowering the significance of prostate cancer in the population.
By Distribution Channel Analysis
Retail pharmacies segment held a substantial market revenue share in 2025
The retail pharmacies segment held a substantial market revenue in 2025, which is augmented owing to the prevalence of consumers purchasing their medication at retail outlets. The higher familiarity and increased trust among the retailers are the main contributing factors leading to higher revenue for finasteride in retail pharmacies.
However, the rising number of telemedicine providers with user-friendly interfaces and e-commerce portal penetration with enhanced internet connections is likely to promote the demand for finasteride in online pharmacies. The growing prominence of offers by e-commerce companies is positively driving sales. For instance, in January 2023, Amazon introduced a new drug subscription monthly scheme with a $5 fee, enabling people to consume as many drugs as they can at a flat price.
Regional Insights
North America region registered the largest share of the global market in 2025
The North American region registered the largest share of the global market in 2025. Region’s growth is due to the rising number of males population suffering from androgenic alopecia. The presence of established players engaged in the production process of finasteride is optimally boosting the expansion of the finasteride market in this region.
Based on market analysis, Asia Pacific will grow at a rapid pace, owing to the increasing healthcare investment in the major countries to promote the availability of prominent drugs, including finasteride, to the population. The significant rise in the penetration of hair loss and benign prostatic enlargement within the male population is projected to boost demand for finasteride in the coming years. According to the statistics unveiled by the health tech company Traya in 2023, approximately 50.31% of Indian men under the age of 25 are witnessing hair loss problems in India.
Key Market Players & Competitive Insights
Strategic agreements to drive the competition
Based on market research, finasteride market is fairly consolidated with the presence of a few larger players with a large market revenue in the global market. The growing patent agreements, collaborations, and partnerships are expected to bolster market expansion. For instance, in April 2023, Blue Water purchased Entadfi, an enlarged prostate drug from Veru that is developed by combining finasteride and tadalafil, for $100 million.
Some of the major players operating in the global market include:
- Accord Pharmaceuticals (UK)
- Teva Pharmaceutical Industries Ltd.
- Cipla (India)
- Merck (Germany)
- Mylan N.V. (US)
- RelonChem (UK)
- Sandoz (Switzerland)
- Topfond Pharmaceutical Co., Ltd.
- Dr. Reddy's Laboratories (UK) Ltd.
- Novartis AG
Recent Developments in the Industry
- In January 2023, Happy Head, a healthcare provider focusing on haircare and treatments, introduced its first all-in-one hair growth super capsule with a combination of Vitamin D, Minoxidil, and Finasteride.
Report Coverage
The finasteride market report emphasizes key regions across the globe to provide a better understanding of the product to the users. Also, the market report provides market insights into recent developments and trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the market research report covers an in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.
The report provides a detailed analysis of the market while focusing on various key aspects such as competitive analysis, product, application, distribution channel, and their futuristic growth opportunities.
Finasteride Market Report Scope
|
Report Attributes |
Details |
|
Market Size in 2025 |
USD 106.06 Million |
| Market Size in 2026 | USD 108.64 Million |
|
Revenue Forecast in 2034 |
USD 135.98 Million |
|
CAGR |
2.8% from 2026 – 2034 |
|
Base Year |
2025 |
|
Historical Data |
2021 – 2024 |
|
Forecast Period |
2026 – 2034 |
|
Quantitative Units |
Revenue in USD million and CAGR from 2026 to 2034 |
|
Segments Covered |
|
|
Regional Scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, region and segmentation. |
FAQ's
The global finasteride market size is expected to reach USD 135.98 million by 2034
Key players in the market are Accord Pharmaceuticals, Actavis, Cipla, Henan Topfond, Merck, Mylan N.V
North America contribute notably towards the global Finasteride Market
Finasteride Market exhibiting a CAGR of 2.8% during the forecast period.
The Finasteride Market report covering key segments are product, application, distribution channel and region.
Page last updated on:
Feb-2024
Research Methodology
A robust system of research, verification, and forecasting designed to ensure reliable and actionable market insights.
Polaris Market Research uses a clear and structured approach to deliver insights that clients can rely on. The process combines detailed primary and secondary research, including direct communication with industry experts. The detailed information helps build a complete picture of market trends and developments. Secondary data is gathered from credible sources such as industry reports, company filings, government source links, and trusted organization databases. It is then cross-checked through discussions with key stakeholders across the value chain. Market size and forecasts are developed using both bottom-up and top-down methods to ensure accuracy and consistency in the final results.
Project Setup
Step 1 & 2:
- We start every project by clearly understanding the client’s objective or goal, then defining the market scope, and aligning regions, segments, and timelines.
- Once the foundation is set, we collect data from all-around of sources, including company reports, government databases, and paid industry platforms.
- Our research is based on secondary data, which helps us build a strong understanding of the market across regions and industries. Then we validate this information through primary research by speaking directly with industry experts, companies, and stakeholders.
- By combining secondary and primary research, we ensure that our market insights are accurate, practical, and closely aligned with real market conditions.
Data Collection
We gather information from both public and verified sources:
Data Structuring
Step 3:
- All collected data is organized into a consistent format to ensure accurate analysis. Since inputs come from multiple sources, they are standardized and aligned before use.
- The data is segmented by product, application, and region, and mapped across a defined historical period (2020–2024). All values are converted into common units (USD Mn/Bn), and volume and pricing are aligned where required to estimate revenue.
- Any overlaps or inconsistencies are reviewed and adjusted to maintain accuracy (<5% variance threshold).
- The result is a structured dataset that allows for clear comparison across regions and supports reliable analysis and forecasting.
Structured Market Dataset, USD Mn/Bn
4. Data Structuring
Step 4: TOP-DOWN APPROACH
- We start with the overall market size at a global or macro level.
- The market is then narrowed down based on scope and industry relevance.
- We apply penetration rates and split the data by region and segment.
- This helps us estimate the market size for specific segments.
- The numbers are validated through cross-checks to ensure accuracy.
Step 5: BOTTOM-UP APPROACH
- We begin by analyzing data from leading companies in the market.
- Revenue data is collected and mapped across different segments.
- The data is then aggregated to estimate the total market size.
- To fill in any gaps, adjustments are made based on industry standards.
- Validation checks make sure that the results are correct.
5. Data Structuring
Step 6:
At Polaris Market Research, we employ a methodical forecasting strategy. This approach blends the analysis of historical data with real-time market validation. To forecast future trends with precision, we examine past patterns, pricing fluctuations, and the interplay of supply and demand. To ensure our conclusions reflect the present market landscape, we actively seek input from industry experts and key stakeholders.
To refine our predictions, we carefully consider critical elements such as market drivers and restraints, fluctuations in raw material costs, emerging technologies, and the production capabilities of various regions. Furthermore, we assess regulatory frameworks and potential policy shifts to gauge their potential impact on market expansion.
All this information is synthesized to generate precise forecasts for each segment and region. These forecasts illuminate the current state of the market and highlight forthcoming opportunities.
6. Data Structuring
Step 7:
In the final stage, we validate all our estimates using a triangulation method, where data is cross-checked from multiple reliable sources, like company data, primary interviews, and secondary research. This helps us make sure that our numbers are correct and fit with the rest of the market.
This process involves verifying data consistency across various segments and geographic areas. It also requires comparing historical trends with the assumptions support the forecast. Any discrepancies involve adjustments to ensure everything remains aligned and dependable.
Once the data is finalized, we prepare the final outputs, including market size estimates, segment-wise breakdowns, and growth metrics. These are delivered in structured formats such as tables, charts, and data files for easy analysis and use.
We collaborate closely with clients, ensuring the final products align with their requirements. This includes offering tailored adjustments, supplementary data analyses, and continuous assistance. Furthermore, we monitor market trends post-delivery, providing updates and refinements to maintain the insights' relevance as time passes.
Post-delivery, we continue to monitor market shifts, offering updates and adjustments to ensure the insights remain relevant over time.
Validation
Triangulation Framework
- Company-level data
- Primary inputs from industry participants
- Secondary benchmarks and published data
- Variance maintained within ±5-10%
- Adjustments applied to align estimates
- Segment values validated against overall market structure
Quality Check
Data Consistency & Integrity
- Segment totals validated to 100%
- Regional estimates aligned with global market size
- Historical trends compared against forecast outputs
- Assumptions reviewed for cross-segment and regional alignment
Output & Delivery
Final Outputs
- Market size estimates (USD Mn/Bn)
- Segment-wise distribution (%)
- Growth metrics (CAGR %)
- Structured tables and charts
- Segment-level datasets
- Excel-based data files for further analysis
Client Alignment & Support
- Deliverables are aligned with defined client requirements and scope
- Custom data cuts and segment splits are incorporated as required
- Post-delivery queries are addressed through analyst interactions
- Additional clarifications and data support are provided upon request
Client Continuity & Updates
- Market developments are tracked post-delivery to capture changes in key trends
- Updated data and revisions are provided based on new market inputs
- Additional refinements and data cuts are shared as required
- Continued analyst engagement supports evolving client requirements
